Fedha

Hisa unazofuatilia
Kwa nini MRK imeongezeka kwa 3.80%?
Fahamu zaidi
MRK:NYSE
Merck & Co.
US$ 147.37
+3.80%
(+5.39) Siku 1
US$ 148.50
+0.77% (+1.13)
Baada ya saa
Imefungwa: 14 Okt, 16:03:33 GMT -4  ·   USD
Alama zote
AlamaBeiTofautiTofauti ya asilimia
Inatayarisha maarifa maarufu ya MRK...
Fungua
US$ 143.10
Juu
US$ 148.16
Chini
US$ 142.66
Mtaji wa soko
363.59B
Wastani wa kiasi cha mauzo
9.33M
Kiasi cha mauzo ya hisa
9.81M
Gawio
2.31%
Mgawo wa faida wa kila robo mwaka
US$ 0.85
Tarehe ya kutojumuisha gawio
15 Sep 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
117.71
Juu kwa wiki 52
US$ 156.92
Chini kwa wiki 52
US$ 82.01
EPS
US$ 1.25
Beta
0.21
Hisa za wawekezaji
2.47B
Idadi ya wafanyakazi
elfu 74
Fungua
US$ 143.10
Juu
US$ 148.16
Chini
US$ 142.66
Mtaji wa soko
363.59B
Wastani wa kiasi cha mauzo
9.33M
Kiasi cha mauzo ya hisa
9.81M
Gawio
2.31%
Mgawo wa faida wa kila robo mwaka
US$ 0.85
Tarehe ya kutojumuisha gawio
15 Sep 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
117.71
Juu kwa wiki 52
US$ 156.92
Chini kwa wiki 52
US$ 82.01
EPS
US$ 1.25
Beta
0.21
Hisa za wawekezaji
2.47B
Idadi ya wafanyakazi
elfu 74
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Wasifu
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue. The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products. The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000. In 1891, Merck & Co. was established as the American affiliate of the Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck". Wikipedia
Kuhusu Merck & Co.
Afisa Mkuu Mtendaji (CEO)Robert M Davis
Wafanyakazielfu 74
Lilianzishwa1 Jan 1891
Makao makuu-
Sekta-
Tovutimerck.com
Ukadiriaji wa mchanganuzi
Kulingana na wachanganuzi 21 waliotoa ukadiriaji wa hisa kwa MRK katika miezi 3 iliyopita
Nunua
Nunua
15
Shikilia
6
Uza
0
Utabiri wa miezi 12
Kulingana na wachanganuzi 21 wa Wall Street wanaotoa makadirio ya bei ya miezi 12 ya MRK katika miezi 3 iliyopita.
Juu kabisa
Ya sasa US$ 147.37
US$ 180.00 (+22.14%)
Wastani
US$ 160.24 (+8.73%)
Chini kabisa
US$ 105.00 (-28.75%)
Mchanganuzi
Unaopendekezwa
Kitendo
Bei lengwa
Unaokadiriwa
Tarehe
Evan Seigerman
BMO Capital
Buy
Maintained
US$ 170.00
+15.4%
10/12/2026
Carter Gould
Cantor Fitzgerald
Hold
Maintained
US$ 145.00
-1.6%
10/11/2026
Daina Graybosch
Leerink Partners
Buy
Maintained
US$ 161.00
+9.2%
10/12/2026
Trung Huynh
RBC Capital
Hold
Reiterated
US$ 145.00
-1.6%
10/12/2026
Geoff Meacham
Citi
Hold
Maintained
US$ 145.00
-1.6%
10/13/2026
Emily Field
Barclays
Buy
Maintained
US$ 150.00
+1.8%
10/12/2026
Michael Yee
UBS
Buy
Maintained
US$ 175.00
+18.7%
10/09/2026
Jason Gerberry
Bank of America Securities
Buy
Maintained
US$ 163.00
+10.6%
10/09/2026
Terence Flynn
Morgan Stanley
Buy
Maintained
US$ 177.00
+20.1%
10/07/2026
Chris Schott
J.P. Morgan
Buy
Maintained
US$ 165.00
+12%
10/05/2026
Asad Haider
Goldman Sachs
Buy
Maintained
US$ 160.00
+8.6%
09/30/2026
Louise Chen
Scotiabank
Buy
Maintained
US$ 180.00
+22.1%
09/29/2026
Steve Scala
TD Cowen
Hold
Maintained
US$ 155.00
+5.2%
09/22/2026
Nico Chen
DBS
Buy
Maintained
US$ 180.00
+22.1%
09/11/2026
Rajesh Kumar
HSBC
Buy
Maintained
US$ 172.00
+16.7%
09/10/2026
Vamil Divan
Guggenheim
Buy
Reiterated
US$ 170.00
+15.4%
09/08/2026
Courtney Breen
Bernstein
Hold
Maintained
US$ 105.00
-28.8%
09/07/2026
Mohit Bansal
Wells Fargo
Buy
Reiterated
US$ 170.00
+15.4%
09/04/2026
Jasper Hellweg
Argus Research
Buy
Reiterated
US$ 170.00
+15.4%
08/24/2026
Alexandria Hammond
Wolfe Research
Buy
Maintained
US$ 180.00
+22.1%
08/25/2026
Luisa Hector
Berenberg Bank
Hold
Maintained
US$ 127.00
-13.8%
08/05/2026
Unknown Analyst
Jefferies
Buy
Maintained
US$ 138.00
-6.4%
05/19/2026
Unknown Analyst
Argus Research
Buy
Reiterated
US$ 130.00
-11.8%
05/08/2026
Hans Engel
Erste Group
Hold
Maintained
-
-
05/05/2026
Natalya Davies
Rothschild & Co Redburn
Buy
Maintained
US$ 179.00
+21.5%
04/17/2026
James Shin
Deutsche Bank
Buy
Upgraded
US$ 150.00
+1.8%
02/13/2026
Ripoti ya mwisho
4 Ago 2026
Kipindi cha Kifedha
Robo2 2026
-US$ 0.13 / -US$ 0.26
+49.43%umepitiliza
Mapato dhidi ya makadirio (USD)
16.61B / 16.37B
+1.46%umepitiliza
Mkutano pepe wa kujadili mapato ya robo ya Robo ya 2 ya mwaka wa fedha wa 2026
Inasubiri mkutano pepe wa kujadili mapato
Kwa muhtasari
Maarifa kutoka kwenye ripoti na habari za hivi punde
Ripoti za awaliThamani zote katika USD
Loading Previous Earnings...
Mapato
Mapato halisi
Thamani zote katika USD
Sep 2025
Des 2025
Mac 2026
Jun 2026
Mapato
17.28B
16.40B
16.29B
16.61B
Gharama ya bidhaa zilizouzwa
3.74B
4.30B
3.88B
4.13B
Gharama ya mapato
3.74B
4.30B
3.88B
4.13B
Gharama za utafiti na maendeleo
4.00B
4.00B
3.56B
9.74B
Jumla ya gharama za utafiti na maendeleo
-
-
-
-
Gharama za uuzaji, za jumla na za usimamizi
2.48B
2.73B
2.57B
2.78B
Gharama ya uendeshaji
6.48B
6.73B
6.12B
12.52B
Jumla ya gharama za uendeshaji
10.23B
11.02B
10.00B
16.65B
Mapato ya uendeshaji
7.05B
5.38B
6.29B
-40.00M
Mapato mengine yasiyo ya uendeshaji
-
41.00M
42.00M
59.00M
EBT ikijumuisha vipengee visivyo vya kawaida
6.74B
3.42B
-3.53B
-683.00M
EBT bila kujumuisha vipengee visivyo vya kawaida
6.76B
4.98B
5.85B
-508.00M
Gharama ya kodi ya mapato
958.00M
458.00M
709.00M
654.00M
Kiwango cha kodi kinachotumika
14.20%
13.39%
-20.06%
-95.75%
Gharama nyingine za uendeshaji
-
-
-
-
Mapato halisi
5.78B
2.96B
-4.24B
-1.34B
Kiwango cha faida halisi
33.49%
18.07%
-26.03%
-8.04%
Mapato kwa kila hisa
2.58
2.04
-1.28
-0.13
Mapato ya riba na uwekezaji
96.00M
69.00M
35.00M
35.00M
Gharama ya riba
-327.00M
-411.00M
-479.00M
-525.00M
Jumla ya gharama halisi za riba
-231.00M
-342.00M
-444.00M
-490.00M
Gharama za kushuka kwa thamani na za kulipa deni
-
-
-
-
Mapato ya kampuni kabla ya riba, kodi, kushuka thamani na kulipa madeni
8.15B
6.79B
7.69B
1.43B
Faida au hasara kutokana na uuzaji wa vipengee
-
-
-
-
Miamala ya wajuzi wa mambo
Data ya miamala ya watu wenye hisa hutolewa kwenye vyanzo vya washirika wengine. Pata maelezo zaidi
Mjuzi wa mambo
Nafasi
Aina
Tarehe
Hisa
Kiasi
Ukurasa wa 1
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
Programu za Google